Maturity‐Onset Diabetes of the Young (MODY) With HNF1B p.Glu105Lys Mutation Achieving Significant Insulin Reduction on Tirzepatide: A Case Report

ABSTRACT This report describes the first case of maturity‐onset diabetes in young (MODY) with HNF1B mutation started administration of the dual glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1 receptor agonist, tirzepatide. A 26‐year‐old female with a 15‐year history of diabe...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Mihiro Sue, Mayu Watanabe, Ayumi Inoue, Akihiro Katayama, Sanae Teshigawara, Yuichi Matsushita, Masaya Takeda, Izumi Iseda, Jun Eguchi, Kazuyuki Hida
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Wiley 2025-02-01
Schriftenreihe:	Clinical Case Reports
Schlagworte:	glucagon‐like peptide‐1 (GLP‐1) glucose‐dependent insulinotropic polypeptide (GIP) maturity‐onset diabetes in young (MODY) tirzepatide
Online-Zugang:	https://doi.org/10.1002/ccr3.70173
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!